Novel investigational drugs for constipation-predominant irritable bowel syndrome: a review.
about
Polyunsaturated Fatty Acids and Their Derivatives: Therapeutic Value for Inflammatory, Functional Gastrointestinal Disorders, and Colorectal CancerFuture Treatment of Constipation-associated Disorders: Role of Relamorelin and Other Ghrelin Receptor Agonists.Neuroimmune Cross Talk in the Gut. Neuroendocrine and neuroimmune pathways contribute to the pathophysiology of irritable bowel syndrome.Targeting Histamine Receptors in Irritable Bowel Syndrome: A Critical Appraisal.
P2860
Novel investigational drugs for constipation-predominant irritable bowel syndrome: a review.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Novel investigational drugs fo ...... able bowel syndrome: a review.
@en
type
label
Novel investigational drugs fo ...... able bowel syndrome: a review.
@en
prefLabel
Novel investigational drugs fo ...... able bowel syndrome: a review.
@en
P2860
P1476
Novel investigational drugs fo ...... able bowel syndrome: a review.
@en
P2093
Maciej Salaga
Paula Mosińska
P2860
P304
P356
10.1517/13543784.2016.1142532
P407
P50
P577
2016-01-14T00:00:00Z